Taipei has approved six US-linked defense procurement deals totaling 208.77 billion New Taiwan dollars ($6.6 billion), which include a co-production program for large-caliber ammunition.
The agreements were concluded with the American Institute in Taiwan after lawmakers authorized Letters of Offer and Acceptance as part of ongoing budget reviews.
Key acquisitions include M142 HIMARS systems worth 123.53 billion New Taiwan dollars ($3.9 billion), M109A7 Paladin units valued at 73.89 billion New Taiwan dollars ($2.3 billion), and 5.32 billion New Taiwan dollars ($168.7 million) for missile inventory replenishment for the Republic of China Army.
The HIMARS program is scheduled for completion by December 2032, the Paladin systems by December 2034, and missile resupply by March 2030. Additional funding includes 5.12 billion New Taiwan dollars ($162.4 million) for anti-armor missile systems and 22.87 million New Taiwan dollars ($725,974) for integrated air defense advisory services, both expected by 2030.
Another contract worth 910.44 million New Taiwan dollars ($28.8 million) focuses on joint development and production of large-caliber ammunition, including 105 mm rounds and above. The program, led by Taiwan’s Armaments Bureau, will run until February 2029 and is intended to integrate Taiwan-produced munitions into US supply chains, with potential export opportunities after domestic needs are fulfilled.
This latest spending follows US approval of $11 billion in arms sales to Taiwan in 2025, underscoring Washington’s position as its leading defense supplier, while also intensifying tensions with Beijing over disputes in the South China Sea.
